Answers are grounded in this paper and cite their sources.
Transition metal complexes provide rigid, shape-defined molecular architectures in which the coordination geometry precisely organizes ligand functionality in three dimensions, making them attractive scaffolds for target-based chemical probe discovery. Yet, their broader and prospective use in structure-based virtual screening has remained largely unexplored, due to the absence of structurally diverse, computationally tractable screening libraries. Here, we address this by curating MOSAIC (Metal complex library for Structure-Aided In silico screening), a first collection of 16,901 neutral, drug-like metal complexes assembled directly from experimentally determined geometries deposited in the Cambridge Structural Database. Using MOSAIC , we perform a high-throughput virtual screening campaign against the allosteric pocket of methionine adenosyltransferase 2A (MAT2A), identifying the copper complex Cu1-Complex , for which nano differential scanning fluorimetry (nanoDSF) confirmed strong binding in vitro . The diamagnetic zinc analogue Zn1-Comple x allowed orthogonal binding characterization with ligand-observed and competition NMR studies. Along with Hydrogen–deuterium exchange mass spectrometry (HDX-MS), site-directed mutagenesis and molecular dynamics (MD), these studies show that Zn1-Complex engages the MAT2A through an allosteric pocket, inhibiting enzymatic activity. Together, this establishes MOSAIC as a scalable and generalizable virtual screening platform for transition metal complexes and demonstrates the potential of these metal-based scaffolds as chemical probes to uncover new modes of protein recognition.
No takes yet. Share an insight, caveat, or question.
Kintzel et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: